by Paul | Sep 13, 2016 | xarelto news
A new Xarelto lawsuit has been recently filed against Bayer AG and Janssen Pharmaceutical by a woman who lost his husband to the side effects of this dangerous blood thinner. Plaintiff Anita F. (Case No. 2:16-cv-14021) is seeking compensation in court on behalf of her...
by Paul | Sep 6, 2016 | xarelto news
The drugmaker Portola Pharmaceuticals Inc. announced that on August 17, 2016, the Biologics License Application (BLA) of its new Xarelto antidote AndexXa™ (Andexanet alfa) has been rejected. AndexXa acts by substituting the human Factor Xa, stopping the action of...
by Paul | Aug 8, 2016 | xarelto news
The upcoming Xarelto Multidistrict Litigation has grown to truly epic proportions. To date, a total of 5,853 lawsuits has been centralized in the MDL number 2592 in the Louisiana Eastern District Court. The massive mass tort presided over by Judge Eldon Fallon...
by Paul | Jul 21, 2016 | xarelto news
Despite all the heat Johnson & Johnson and Bayer had to face since over 5,000 plaintiffs filed a Xarelto lawsuit, sales of the powerful anticoagulant kept growing even this year. According to a recent forecast, rivaroxaban still stands out from the crowd as one of...
by Paul | Jun 29, 2016 | xarelto news
A couple from Ohio filed a new Xarelto lawsuit alleging that the drug caused a life-threatening gastrointestinal bleeding and a severe case of anemia. The husband and wife are asking the pharmaceutical companies for a $150,000 compensation to repay the past, present...
by Paul | Apr 26, 2016 | xarelto news
The number of Xarelto lawsuits filed in 2016 kept rising steadily in the United States. Now a substantial number of plaintiffs started seeking for compensatory damage even in Canada. Rivaroxaban is a blood thinner drug marketed by Bayer AG and Janssen Pharmaceutical....
